Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francis J Alenghat

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Scientific Reports|February 5, 2016
The Prevalence of Atherosclerosis in Those with Inflammatory Connective Tissue Disease by Race, Age, and Traditional Risk FactorsFrancis J Alenghat
American Journal of Preventive Cardiology|December 8, 2021
The impact of lipid-lowering medications on coronary artery plaque characteristicsVishnu Priya Pulipati, Francis J Alenghat
JAMA|August 21, 2019
Catheter Ablation for Atrial Fibrillation in 2019Gaurav A Upadhyay, Francis J Alenghat
Science'S STKE : Signal Transduction Knowledge Environment|February 14, 2002
Mechanotransduction: all signals point to cytoskeleton, matrix, and integrinsFrancis J Alenghat, Donald E Ingber
Current Topics in Membranes|November 12, 2013
Membrane protein dynamics and functional implications in mammalian cellsFrancis J Alenghat, David E Golan
European Journal of Preventive Cardiology|June 14, 2019
The SPRINT Trial Score web calculatorLuke J Laffin, Francis J Alenghat
JAMA|February 5, 2019
Management of Blood CholesterolFrancis J Alenghat, Andrew M Davis
European Journal of Preventive Cardiology|November 28, 2018
A data-zone scoring system to assess the generalizability of clinical trial results to individual patientsLuke J Laffin, Stephanie A Besser, Francis J Alenghat
JAMA|November 14, 2024
Management of Atrial FibrillationFrancis J Alenghat, Jason T Alexander, Gaurav A Upadhyay
European Heart Journal|October 26, 2012
Giant left ventricular aneurysm as a late complication of inferior myocardial infarctionFrancis J Alenghat, Gregory S Couper, Michael M Givertz
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Scientific Reports|February 5, 2016
The Prevalence of Atherosclerosis in Those with Inflammatory Connective Tissue Disease by Race, Age, and Traditional Risk FactorsFrancis J Alenghat
American Journal of Preventive Cardiology|December 8, 2021
The impact of lipid-lowering medications on coronary artery plaque characteristicsVishnu Priya Pulipati, Francis J Alenghat
JAMA|August 21, 2019
Catheter Ablation for Atrial Fibrillation in 2019Gaurav A Upadhyay, Francis J Alenghat
Science'S STKE : Signal Transduction Knowledge Environment|February 14, 2002
Mechanotransduction: all signals point to cytoskeleton, matrix, and integrinsFrancis J Alenghat, Donald E Ingber
Current Topics in Membranes|November 12, 2013
Membrane protein dynamics and functional implications in mammalian cellsFrancis J Alenghat, David E Golan
European Journal of Preventive Cardiology|June 14, 2019
The SPRINT Trial Score web calculatorLuke J Laffin, Francis J Alenghat
JAMA|February 5, 2019
Management of Blood CholesterolFrancis J Alenghat, Andrew M Davis
European Journal of Preventive Cardiology|November 28, 2018
A data-zone scoring system to assess the generalizability of clinical trial results to individual patientsLuke J Laffin, Stephanie A Besser, Francis J Alenghat
JAMA|November 14, 2024
Management of Atrial FibrillationFrancis J Alenghat, Jason T Alexander, Gaurav A Upadhyay
European Heart Journal|October 26, 2012
Giant left ventricular aneurysm as a late complication of inferior myocardial infarctionFrancis J Alenghat, Gregory S Couper, Michael M Givertz
Pageof 4